Related Experiment Videos
[Calcium channel blockers and dysthymic disorders. Recent data]
1Service Universitaire de Psychiatrie et de Psychologie Médicale, CHR Purpan Casselardit, Toulouse.
L'Encephale
|January 1, 1992
Summary
Calcium antagonists, like nimodipine, show potential in treating dysthymic disorders and hypomanic states. While efficacy varies, they offer a promising alternative with fewer cognitive side effects than neuroleptics.
Area of Science:
- Pharmacology
- Neuroscience
- Psychiatry
Context:
- Review of calcium antagonists for mental health conditions.
- Focus on verapamil and nimodipine for CNS-acting properties.
Purpose:
- To evaluate the efficacy of calcium antagonists in treating dysthymic disorders.
- To compare their effectiveness and side effect profiles with existing treatments like lithium and neuroleptics.
Summary:
- Calcium antagonists demonstrate consistent therapeutic benefits in hypomanic states.
- Their efficacy in manic states of bipolar disorders is variable when used alone.
- Preventive use, with or without lithium, shows real but inconsistent efficiency.
- Notably, they lack the cognitive disturbances associated with neuroleptics and have fewer side effects than lithium.
Impact:
- Calcium antagonists represent a potentially valuable therapeutic option for dysthymic disorders.
- Their favorable side effect profile, particularly regarding cognitive function, warrants further investigation.